Racial Disparities in Clinical Features and Survival Outcomes among Patients with Pancreatic Neuroendocrine Tumor: A Contemporary SEER Database Analysis

被引:1
|
作者
Wang, Fei [1 ]
Ma, Jihyun [2 ]
Zhao, Nan [3 ]
Lin, Chi [3 ]
Jiang, Haixing [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning 530021, Peoples R China
[2] Univ Nebraska, Dept Biostat, Med Ctr, Omaha, NE USA
[3] Univ Nebraska, Fred & Pamela Buffett Canc Ctr, Dept Radiat Oncol, Med Ctr, Omaha, NE 68198 USA
关键词
Pancreatic neuroendocrine tumors; racial discrepancy; prognosis; SEER; SURGICAL-MANAGEMENT; MARITAL-STATUS; EPIDEMIOLOGY;
D O I
10.32604/oncologie.2022.025447
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The characteristics of clinical features and prognoses among patients with different racial backgrounds have not been clearly studied. We thus investigated the clinical characteristics and overall survival (OS) differ-ences among Asian, White, and Black patients with pancreatic neuroendocrine tumors (pNETs). Materials and Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried to identify patients with pNETs between 1983 and 2015. We performed univariable (UVA) and multivariable logistic regression (MVA) to assess the association between variables and race category. A Kaplan-Meier (KM) plot was used to cal-culate the OS rates. The Cox proportional hazard regression was used to report the hazard of death. Results: We identified 9,494 patients with a median follow-up of 31 months. There were 5,541 Whites (78.6%), 942 Blacks (13.4%), and 569 Asians (8.1%). Asians were more likely to be younger, married, diagnosed at an earlier stage, and have a tumor located at the head of the pancreas. White patients were less likely to be married and had, on average, a higher percentage of the primary tumor at the tail of the pancreas, while Black patients were gen-erally diagnosed at a much later stage. The median OS of Asians (71 months) was significantly higher than that of Whites (50 months, p = 0.03) and Blacks (53 months, p = 0.01). Multivariable Cox regression showed no OS dif-ference among the three races after adjusting for independent prognostic factors, including age, marital status, primary site, TNM stage and treatment. Subgroup analysis in each race showed that age, M stage, and surgical treatment were independent prognostic factors for survival in all three races while being female, married, and in the N0 stage were positive prognostic factors of OS only in Whites. Among patients with surgery, Asians had the best OS. Conclusions: Asians had the best OS among those who received surgery. Age, M stage, and sur-gical treatment were the independent prognostic factors for survival across the three races. Female, married, and in the N0 stage were positive predictive factors for survival only in White patients.
引用
收藏
页码:865 / 895
页数:31
相关论文
共 50 条
  • [21] The effect of marital status on the survival of patients with colorectal neuroendocrine neoplasms: an analysis of the SEER database
    Xiao, Keshuai
    Zhao, Yan
    Cai, Yijie
    Chen, Ping
    Chen, Jianjiao
    Ye, Rongjin
    Yuan, Bing
    Liu, Xinxin
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (02) : 109 - 117
  • [22] Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database
    Cao, Long-Long
    Lu, Jun
    Lin, Jian-Xian
    Zheng, Chao-Hui
    Li, Ping
    Xie, Jian-Wei
    Wang, Jia-Bin
    Chen, Qi-Yue
    Lin, Mi
    Tu, Ru-Hong
    Huang, Chang-Ming
    EJSO, 2018, 44 (10): : 1628 - 1633
  • [23] Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
    Sonbol, Mohamad Bassam
    Mazza, Gina L.
    Mi, Lanyu
    Oliver, Thomas
    Starr, Jason
    Gudmundsdottir, Hallbera
    Cleary, Sean P.
    Hobday, Timothy
    Halfdanarson, Thorvardur R.
    ONCOLOGIST, 2022, 27 (07): : 573 - 578
  • [24] Incidence and survival patterns of pancreatic neuroendocrine tumors over the last two decades: A SEER database analysis
    Sonbol, Mohamad Bassam
    Mazza, Gina L.
    Starr, Jason Scott
    Hobday, Timothy J.
    Halfdanarson, Thorvardur Ragnar
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [25] INCIDENCE RATES AND CANCER CONTROL OUTCOMES OF CONTEMPORARY PRIMARY NEUROENDOCRINE PROSTATE CANCER: ANALYSIS OF SEER DATABASE
    Zaffuto, Emanuele
    Zanaty, Marc
    Bondarenko, Helen Davis
    Pompe, Raisa S.
    Dell'Oglio, Paolo
    Gandaglia, Giorgio
    Fossati, Nicola
    Stabile, Armando
    Zorn, Kevin C.
    Montorsi, Francesco
    Briganti, Alberto
    Karakiewicz, Pierre I.
    JOURNAL OF UROLOGY, 2017, 197 (04): : E900 - E901
  • [26] Incidence and Survival Patterns of Pancreatic Neuroendocrine Tumors Over the Last Two Decades: A SEER Database Analysis
    Sonbol, Mohamad
    Mazza, Gina
    Starr, Jason
    Hobday, Timothy
    Halfdanarson, Thorvardur
    PANCREAS, 2020, 49 (03) : 487 - 487
  • [27] Racial disparities in tumor features and outcomes of patients with squamous cell carcinoma of the tonsil
    Albert, Ashley
    Giri, Shankar
    Kanakamedala, Madhava
    Mangana, Sophy
    Bhanat, Eldrin
    Shenoy, Veena
    Thomas, Toms Vengaloor
    Joseph, Sanjay
    Gonzalez, Maria
    Shalaby, Akram
    Vijayakumar, Srinivasan
    LARYNGOSCOPE, 2019, 129 (03): : 643 - 654
  • [28] Surgical Interventions in Patients With Pancreatic Neuroendocrine Tumors: A SEER-based Survival Analysis
    Rodriguez, Jorge Zarate
    Raper, Lacey
    Sanford, Dominic
    Trikalinos, Nikolaos
    Hammill, Chet
    PANCREAS, 2022, 51 (03) : E53 - E53
  • [29] Racial disparities in survival outcomes among breast cancer patients by molecular subtypes
    Fangyuan Zhao
    Brenda Copley
    Qun Niu
    Fang Liu
    Julie A. Johnson
    Thomas Sutton
    Galina Khramtsova
    Elisabeth Sveen
    Toshio F. Yoshimatsu
    Yonglan Zheng
    Abiola Ibraheem
    Nora Jaskowiak
    Rita Nanda
    Gini F. Fleming
    Olufunmilayo I. Olopade
    Dezheng Huo
    Breast Cancer Research and Treatment, 2021, 185 : 841 - 849
  • [30] Racial disparities in survival outcomes among breast cancer patients by molecular subtypes
    Zhao, Fangyuan
    Copley, Brenda
    Niu, Qun
    Liu, Fang
    Johnson, Julie A.
    Sutton, Thomas
    Khramtsova, Galina
    Sveen, Elisabeth
    Yoshimatsu, Toshio F.
    Zheng, Yonglan
    Ibraheem, Abiola
    Jaskowiak, Nora
    Nanda, Rita
    Fleming, Gini F.
    Olopade, Olufunmilayo, I
    Huo, Dezheng
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (03) : 841 - 849